Inactive Instrument

Other languages Össur hf. Other OTC

Equities

Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024	04-23
Embla Medical hf: Interim Report Q1 2024	04-23
Embla Medical hf. Provides Earnings Guidance for the Year 2024	04-23
Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23
Össur hf. will Change its Name to Embla Medical hf	04-08
Össur hf: Board Decisions Following the Annual General Meeting	03-13
Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	03-13
Össur hf: Results of the Annual General Meeting	03-13
Össur hf: Candidates to the Board of Directors	03-10
Össur hf: Final Agenda and Proposals for the Annual General Meeting 13 March 2024	02-28
Össur hf: Össur establishes new parent organization to be named Embla Medical	02-21
Össur hf Establishes New Parent Organization to Be Named Embla Medical	02-21
Össur hf: Annual General Meeting 13 March 2024	02-21
Transcript : Össur hf., Q4 2023 Earnings Call, Jan 30, 2024	01-30
Össur hf: Annual Report 2023	01-30
Össur hf: Interim Report Q4 2023	01-30
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2023	01-30
Össur hf. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01-30
Össur hf. Provides Earnings Guidance for the Year 2024	01-30
Össur hf: Össur's total share capital following completion of capital increase of 6,636,122 shares	01-24

No results for this search